The journey from radical treatments to the precision of robotic surgery underscores a commitment to innovation and patient-centered care in the field of head and neck oncology. Purpose of review This article provides a comprehensive overview that not only informs but also stimulates ongoing discourse ...
Recent studies suggest that arthropod diversity in German forests is declining. Currently, different national programs are being developed to monitor arthr
Advance directives (ADs) are assumed to reflect the patients’ preferences, even if these are not clearly expressed. Research into whether this assumption is correct has been lacking. This study explores to what extent ADs reflect the true wishes of the
The trial’s aims were to remove traditional barriers to eligibility, as discussed in this paper. The trial included patients with an ECOG performance status of 2, did not mandate strict timing for lab tests and scans, permitted investigator-assessed PFS as opposed to central assessment, used ...
The patients’ performance status was measured according to ECOG Scale Performance Status [25]. Disease progression was defined, according to the Response Evaluation Criteria in Solid Tumors (RECIST), as a new metastatic lesion and/or an ≥20% increase in the sum of diameters of target lesions ...
In clinical prac- tice, this interval is commonly between 4 and 6 weeks; however, the advantages of longer recovery intervals in terms of complication risk must be balanced against the potentially detrimental impact on survival, as demonstrated in a retrospective review of outcomes among more than...
The R-CHOP immunochemotherapy protocol has been the first-line (1L) standard of care (SOC) for diffuse large B-cell lymphoma (DLBCL) patients for decades and is curative in approximately two-thirds of patients. Numerous randomized phase III trials, most